ESSA Pharma Raises $15M In PIPE

Houston- and Vancouver, BC-based ESSA Pharma, which is developing treatments for prostate cancer, said it is raising $15M in a private placement. The private placement is being led by Clarus Lifesciences, and also includes Deerfield Management Company and others. ESSA--which is already publicly listed on the TSX ass EPI and NASDAQ as EPIX--said the new funding will go towards funding research and development, preclinical and clinical expenses, and corporate costs. More information »